The investigational transdermal delivery system, known as Xulane Lo, is designed to deliver 150mcg of norelgestromin and 17.5mcg of ethinyl estradiol per day.

Estradiol 0.025mg/day, 0.0375mg/day, 0.05mg/day, 0.075mg/day, 0.1mg/day; transdermal system. Increased risk of endometrial carcinoma or hyperplasia in women with intact uterus (adding progestin is ...

Once scientists isolated progesterone and figured out its chemical structure, they moved on to explore possible therapeutic treatments using the hormone ... manufacturing a drug suitable for ...

Therefore, there is the prospect of developing structure-based knowledge of those proteins that should be avoided in drug discovery programs, to overcome complicating factors such as drug ...